AE
BDSX icon

AMH Equity’s Biodesix BDSX Stock Holding History

AMH Equity’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,389
Closed -$29.9K – 56
2025
Q1 		$29.9K Sell
2,389
-30,204
-93% -$580K 0.05% 53
2024
Q4 		$997K Sell
32,593
-2,211
-6% -$65.1K 0.98% 27
2024
Q3 		$1.24M Hold
34,804
– – 1.57% 15
2024
Q2 		$1.06M Buy
+34,804
New +$994K 1.41% 19

Other funds holding BDSX

TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

AMH Equity's BDSX Position: Q2 2025 in Review

AMH Equity sold out of Biodesix (BDSX) in Q2 2025, closing a stake of 2,389 shares — an estimated $29.9K sold.

AMH Equity first reported a position in BDSX in Q2 2024 and held it in 4 quarters. The position peaked at $1.24M in Q3 2024. 40 funds tracked by Wall St. Rank hold BDSX as of Q2 2025.

  • AMH Equity reported no remaining Biodesix position as of Q2 2025 after selling out during the quarter.
  • AMH Equity sold 2,389 Biodesix shares in Q2 2025, an estimated $29.9K.
  • AMH Equity first reported a position in Biodesix in Q2 2024 and held it in 4 quarters.
  • AMH Equity's Biodesix position peaked at $1.24M in Q3 2024.
  • 40 funds tracked by Wall St. Rank held Biodesix as of Q2 2025.

Based on AMH Equity's 13F filing for Q2 2025, filed 4 Aug 2025.